Charles River Laboratories International, Inc.
CRL
$175.92
$6.653.93%
| 12/28/2024 | 09/28/2024 | 06/29/2024 | 03/30/2024 | 12/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -1.92% | -3.67% | -2.41% | 0.49% | 3.86% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.92% | -3.67% | -2.41% | 0.49% | 3.86% |
| Cost of Revenue | 1.19% | -1.40% | 0.16% | 1.79% | 4.28% |
| Gross Profit | -7.31% | -7.54% | -6.73% | -1.72% | 3.14% |
| SG&A Expenses | -2.21% | -3.75% | -6.32% | 8.07% | 12.63% |
| Depreciation & Amortization | 0.75% | -5.46% | -5.04% | -5.85% | -6.23% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.46% | -2.06% | -1.45% | 2.73% | 5.47% |
| Operating Income | -15.01% | -12.23% | -7.56% | -10.76% | -4.19% |
| Income Before Tax | -83.98% | -16.01% | -13.94% | -14.60% | -6.69% |
| Income Tax Expenses | -32.79% | -33.84% | -31.31% | -30.66% | -22.60% |
| Earnings from Continuing Operations | -94.74% | -10.93% | -9.06% | -10.06% | -2.48% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 46.26% | 24.51% | 30.90% | -28.87% | 9.97% |
| Net Income | -95.32% | -10.77% | -8.78% | -10.45% | -2.39% |
| EBIT | -15.01% | -12.23% | -7.56% | -10.76% | -4.19% |
| EBITDA | -6.02% | -5.39% | -2.67% | -5.72% | -1.82% |
| EPS Basic | -98.13% | -13.56% | -11.44% | -12.25% | -3.17% |
| Normalized Basic EPS | -18.36% | -6.57% | -4.80% | -9.63% | -2.17% |
| EPS Diluted | -98.35% | -13.46% | -11.39% | -12.04% | -2.67% |
| Normalized Diluted EPS | -18.27% | -6.45% | -4.71% | -9.43% | -1.79% |
| Average Basic Shares Outstanding | 0.30% | 0.58% | 0.73% | 0.76% | 0.82% |
| Average Diluted Shares Outstanding | 0.10% | 0.46% | 0.63% | 0.54% | 0.42% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
